“Tumour Microenvironment Modulation to Overcome Checkpoint Resistance: Where the Preclinical Rationale Holds”. Translational Medicine & Therapeutics Journal, vol. 5, no. 2, Apr. 2026, pp. 28-36, https://doi.org/10.5281/zenodo.22649559.